癌变·畸变·突变 ›› 2008, Vol. 20 ›› Issue (1): 11-014.doi: 10.3969/j.issn.1004-616x.2008.01.003

• 论著 • 上一篇    下一篇

高氡暴露地区人群中代谢酶CYP1A1基因多态性与肺癌易感性的关系

齐雪松1,夏 英1,孙全富1,尚 兵1,吕慧敏3,程同心2,崔宏星1,冯顺治3,王利平1,王 浩3,孙粉珍3   

  1. 1.中国疾病预防控制中心辐射防护与核安全医学所,北京 100088; 2.甘肃庆阳市地方病防治协调领导小组;3.庆阳市人民医院,甘肃 庆阳市 745100
  • 收稿日期:2007-11-13 修回日期:2007-11-20 出版日期:2008-01-30 发布日期:2008-01-30

Association between Genetic Polymorphisms of CYP1A1 and Lung Cancer Susceptibility for People Living in High Radon-exposed Area

QI Xue-song1, XIA Ying1, SUN Quan-fu1, SHANG Bing1,LU Hui-ming1, CHENG Tong-xin2, CUI Hong-xing1, FENG Shun-zhi2,WANG Li-ping1, WANG Hao3, SUN Fen-zhen3   

  1. National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing
  • Received:2007-11-13 Revised:2007-11-20 Online:2008-01-30 Published:2008-01-30

摘要: 背景与目的: 研究高氡暴露地区人群中CYP1A1基因多态性与肺癌易感性的关系。 材料与方法: 采用病例-对照研究方法,以基因体外扩增限制性片段长度多态性分析(RFLP-PCR)技术,对高氡暴露地区53例肺癌患者和72例对照人员进行了代谢酶CYP1A1(MSPⅠ)基因多态性检测,并分析了不同人群中该基因多态性与肺癌发病风险的关系。 结果: 在氡暴露地区CYP1A1(MSPⅠ) 基因杂合型人群的肺癌发病的OR(优势比)值为1.03(95%可信限 0.468~2.30)。分层分析:有效剂量<50 mSv的人群中CYP1A1(MSPⅠ) 基因杂合型的肺癌发病风险增至4.29倍(95%可信限 0.582~88.2),年龄在40~59岁人群中CYP1A1(MSPⅠ) 基因杂合型的肺癌发病风险是野生型的1.22倍(95%可信限 0.145~3.65)。 结论: CYP1A1(MSPⅠ)基因多态性与肺癌易感性无显著关联,但CYP1A1(MSPⅠ)基因杂合型对观察人群的肺鳞癌发病风险、有效剂量<50 mSv的人群肺癌发病风险、非吸烟人群的肺癌发病风险和40~59岁人群肺癌发病风险均有增高的趋势。

关键词: 氡, CYP1A1, 基因多态性, 肺癌易感性

Abstract: BACKGROUND AND AIM: To assess the role of genetic polymorphisms of metabolic enzyme Cytochrome P450 1A1(CYP1A1) in the risk of developing lung cancer for the people living in high radon-exposed area. MATERIALS AND METHODS: A case-control study was performed with 53 lung cancer patients and 72 frequency-matched controls. The associations between genotypes and risk of developing lung cancer were estimated by odds ratios (ORs) and their 95% confidence intervals (CIs) calculated by unconditional logistic regression. RESULTS: Risk of developing lung cancer for heterozygous CYP1A1 (MSPⅠ) polymorphism was 1.03-fold (95%CI 0.468-2.28) higher than that for wild type of CYP1A1 (MSPⅠ) polymorphism. Stratified analysis showed that with effective dose<50 mSv the risk of developing lung cancer for heterozygous CYP1A1 (MSPⅠ) polymorphism increased to 4.29-fold (95%CI 0.582-88.2). In people heterozygous for CYP1A1 (MSPⅠ) polymorphism aged between 40 and 59, the risk of developing lung cancer was 1.22-fold higher than that for wild type of CYP1A1 (MSPⅠ) polymorphism. CONCLUSION: The present results indicated genetic polymorphisms of CYP1A1 might increase the risk of developing lung cancer, but the difference was not statistically significant.

Key words: radon, CYP1A1, genetic polymorphisms, lung cancer susceptibility